What's at stake for the next wave of coronavirus vaccines

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:

• $4We looked at how the $4 are $4;
• $4;
• We found $4.

If you're new to this newsletter, $4 Tips, comments? Email me at lramsey@insider.com or tweet $4. Let's get to it...

>$4

$4

As the rollout of three authorized vaccines continues here in the US, other drugmakers are still carrying on in their pursuits to arm the world with more effective shots.

$4, Andrew Dunn reports.

The companies are now looking at approval by the end of 2021.

Meanwhile, $4, which is close to getting the green light from the Food and Drug Administration for its coronavirus vaccine, still faces a key challenge.

Can it finish what it started?

$4

$4

>$4

$4

The funding boom for healthcare startups is, as you might expect, not slowing down just yet.

Healthcare startups raised $31.6 billion in the first three months of 2021, $4.

Megan Hernbroth broke $4. Surprise, surprise: $4 at the top of the list.

All the funding is turning into M&A activity.

Most recently - $4.

It's a case of a well-funded startup (Ro) acquiring a smaller company (Modern Fertility) to keep growing.

And Ro isn't the only one acquiring. Cedar last week said it's $4, and Grand Rounds in March said that it's buying telehealth startup Dr. On Demand.

We're calling it the start of a "consolidation tsunami."

$4

$4